Sarepta Therapeutics to Present at the Evercore ISI HealthCONx Conference

Rhea-AI Summary

Sarepta Therapeutics (NASDAQ:SRPT) announced that its senior management will participate in a fireside chat during the 5th Annual Evercore ISI HealthCONx Conference on December 1, 2022, at 2:15 p.m. E.T. The event will be held virtually and available for live streaming on the investor relations section of Sarepta's website. The presentation will remain archived for 90 days post-event. Sarepta is dedicated to developing precision genetic medicine for rare diseases, with over 40 programs in development.

CAMBRIDGE, Mass., Nov. 23, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in a fireside chat at the 5th Annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022 at 2:15 p.m. E.T. The fireside chat will be held virtually.

The presentation will be webcast live under the Events & Presentations section of the investor relations section of Sarepta’s website at https://investorrelations.sarepta.com/events-presentations and will be archived there following the presentation for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Sarepta Therapeutics
Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.

Internet Posting of Information
We routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.

Source: Sarepta Therapeutics, Inc.

Investor Contact:
Ian Estepan, 617-274-4052
iestepan@sarepta.com

Media Contact:
Tracy Sorrentino, 617-301-8566
tsorrentino@sarepta.com

FAQ

What is the date and time of Sarepta's fireside chat at the Evercore ISI HealthCONx Conference?

Sarepta's fireside chat is scheduled for December 1, 2022, at 2:15 p.m. E.T.

Where can I watch the Sarepta Therapeutics presentation during the conference?

The presentation can be watched live on Sarepta's investor relations website under the Events & Presentations section.

How long will the Sarepta Therapeutics conference presentation be available for viewing?

The presentation will be archived on Sarepta's website for 90 days following the event.

What is Sarepta Therapeutics known for?

Sarepta is known for its leadership in precision genetic medicine, specifically for rare diseases like Duchenne muscular dystrophy.

How many programs is Sarepta Therapeutics currently developing?

Sarepta Therapeutics is currently developing over 40 programs in various stages of development.